featured
Oral Ixazomib Maintenance Following Auto-SCT
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Oral Ixazomib Maintenance Following Autologous Stem Cell Transplantation (TOURMALINE-MM3): A Double-Blind, Randomised, Placebo-Controlled Phase 3 Trial
Lancet 2018 Dec 10;[EPub Ahead of Print], MA Dimopoulos, F Gay, F Schjesvold, M Beksac, R Hajek, KC Weisel, H Goldschmidt, V Maisnar, P Moreau, CK Min, A Pluta, WJ Chng, M Kaiser, S Zweegman, MV Mateos, A Spencer, S Iida, G Morgan, K Suryanarayan, Z Teng, T Skacel, A Palumbo, AB Dash, N Gupta, R Labotka, SV RajkumarFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.